Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169113 · ClinicalTrials.gov registry record · NA
Opiate Prescribing Guidelines Following Hip Arthroscopy
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT04169113: Completed NA study, sponsored by Northwestern University.
NCT04169113 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04169113, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if opiates are required to achieve appropriate analgesia after hip arthroscopy in outpatient surgery. The investigators hypothesize that patients are frequently prescribed more opiates than are needed after surgery, resulting in excess medications that are at risk for misuse, diversion and contribution to the opioid epidemic
Primary Outcome
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
Interventions
- OTHER Group 1 - Opiate Tablets post Hip Arthroscopy
- OTHER Group 2 - Opiate Tablets post Hip Arthroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2018-06-12 |
| Est. Completion | 2020-07-08 |
| Phase | NA |
What the finished NCT04169113 record still lists
NCT04169113 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Group 1 - Opiate Tablets post Hip Arthroscopy is the first listed.
NCT04169113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04169113 about?
NCT04169113 is a clinical study titled "Opiate Prescribing Guidelines Following Hip Arthroscopy". The purpose of the study is to determine if opiates are required to achieve appropriate analgesia after hip arthroscopy in outpatient surgery. The investigators hypothesize that patients are frequently prescribed more opiates than are needed after surgery, resulting in excess medications that are at...
What is the current status of trial NCT04169113?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2018-06-12. Estimated completion is 2020-07-08.
What interventions are being tested in trial NCT04169113?
The interventions under investigation include: Group 1 - Opiate Tablets post Hip Arthroscopy (OTHER), Group 2 - Opiate Tablets post Hip Arthroscopy (OTHER).
Who is sponsoring clinical trial NCT04169113?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04169113's enrollment target sits among peer trials
111 816th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI